Home
Products
Heterocyclic Building Blocks
Oxadiazole/Thiadiazole
5-Methyl-1,3,4-oxadiazole-2-carboxylic acid potassium salt

5-Methyl-1,3,4-oxadiazole-2-carboxylic acid potassium salt - CAS 888504-28-7

Name: 5-Methyl-1,3,4-oxadiazole-2-carboxylic acid potassium salt
Brand: BOC Sciences
Rating: 5 (1 reviews)

Catalog:	BB039272
Product Name:	5-Methyl-1,3,4-oxadiazole-2-carboxylic acid potassium salt
CAS:	888504-28-7
Synonyms:	potassium;5-methyl-1,3,4-oxadiazole-2-carboxylate

Technical Data

Safety and Hazards

Patents

Computed Properties

IUPAC Name:	potassium;5-methyl-1,3,4-oxadiazole-2-carboxylate
Description:	An intermediate in the preparation of HIV-integrase inhibitors.
Molecular Weight:	166.18
Molecular Formula:	C4H3KN2O3
Canonical SMILES:	CC1=NN=C(O1)C(=O)[O-].[K+]
InChI:	InChI=1S/C4H4N2O3.K/c1-2-5-6-3(9-2)4(7)8;/h1H3,(H,7,8);/q;+1/p-1
InChI Key:	BRHMYHXNUGVBCU-UHFFFAOYSA-M
Purity:	95 %
Appearance:	Off-white solid
MDL:	MFCD08060085
LogP:	-0.00090

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Oxadiazole/Thiadiazole

[938459-06-4]C7H13N3O
1-(5-Isopropyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
[1018125-37-5]C11H9FN2O3
Ethyl 3-(2-fluorophenyl)-1,2,4-oxadiazole-5-carboxylate
[91393-16-7]C12H12N2O3
Ethyl 3-(4-methylphenyl)-1,2,4-oxadiazole-5-carboxylate
[96898-36-1]C11H9N3O5
Ethyl 3-(4-nitrophenyl)-1,2,4-oxadiazole-5-carboxylate
[956729-63-8]C9H9N5O5
Ethyl 3-[(3-nitro-1H-pyrazol-1-yl)methyl]-1,2,4-oxadiazole-5-carboxylate
[956264-16-7]C9H9BrN4O3
Ethyl 3-[(4-bromopyrazolyl)methyl]-1,2,4-oxadiazole-5-carboxylate

GHS Hazard Statement:	H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]
Precautionary Statement:	P201, P202, P261, P264, P271, P280, P281, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501
Signal Word:	Warning

Publication Number	Title	Priority Date
CN-113272309-A	Tricyclic inhibitors of hepatitis B virus	20180810
US-2020330466-A1	Process for the preparation of raltegravir	20171114
EP-3472134-B1	Process for preparing compounds useful as intermediates for the preparation of raltegravir	20160621
CA-2995099-A1	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication	20150812
JP-2018522926-A	Pyridin-3-ylacetic acid derivatives as inhibitors of human immunodeficiency virus replication	20150812

Complexity:	132
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	2
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	165.97807345
Formal Charge:	0
Heavy Atom Count:	10
Hydrogen Bond Acceptor Count:	5
Hydrogen Bond Donor Count:	0
Isotope Atom Count:	0
Monoisotopic Mass:	165.97807345
Rotatable Bond Count:	1
Topological Polar Surface Area:	79 Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0